Compare Enovix Corporation (ENVX) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Oscar Health Inc — how do they compare? Enovix Corporation trades at $2.46 (market cap $549.72M), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 18.6× Enovix Corporation's market cap, and Oscar Health Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Oscar Health Inc for 15 Days on average.
| ENVX | OSCR | |
|---|---|---|
Market Cap | $549.72M | $10.22B |
Volume | 6,635,687 | 4,123,394 |
Sector | Industrials | Health |
52-Week High | $13.19 | $33.81 |
52-Week Low | $2.50 | $10.85 |
Typical Hold Time | 11 Days | 15 Days |
Enterprise Value | $611.42M | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.46, down 3.53% on the day, with technical indicators signaling a bearish trend. The company reported a net loss of $156.74 million in 2025, with revenue of $31.82 million, and continues to burn cash, though it has beaten EPS estimates in recent quarters. Recent news includes CEO transition and expansion of battery manufacturing capacity.
Despite consistent EPS beats, ENVX faces significant financial challenges with negative margins and cash burn. Analyst consensus is bullish with a $10.75 price target, but high execution risk and leadership changes pose threats to near-term stability and long-term growth prospects.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
